Miramar Labs logo — Advanced medical devices specifically designed to address un...

Miramar Labs

Advanced medical devices specifically designed to address underarm hyperhidrosis in adults, providing targeted treatment for enhanced comfort and confidence.

Founded 2006 Venture round Total: $100.65M Health Care, Medical Devices +1

General Information

Company Name Miramar Labs
Founded Year 2006
Founders / Decision Makers
Team member
Industries Health Care, Medical Devices, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Miramar Labs. To contact Miramar Labs, visit miradryhcp.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Miramar Labs

Miramar Labs is a company specializing in creating advanced medical devices specifically designed to address underarm hyperhidrosis in adults. Their miraDry System is tailored to provide targeted treatment for enhanced comfort and confidence in individuals suffering from primary underarm hyperhidrosis. Established in 2006, the company is headquartered in Sunnyvale, California. Focused on the healthcare, medical devices, and pharmaceutical industries, Miramar Labs received its last Venture Round investment on June 8, 2016. The investment was made by notable firms such as Domain Associates, Morgenthaler Ventures, Aisling Capital, RusnanoMedInvest, and Montrose Capital Partners. With a dedicated focus on addressing underarm hyperhidrosis, Miramar Labs has garnered attention and investment from prominent stakeholders within the medical and venture capital sectors.

Taxonomy: Hyperhidrosis Treatment, Aesthetic Treatment, Adult Healthcare, Medical Technology, Underarm Treatment, Miramar Labs, miraDry System, Sunnyvale, California, Axillary Hyperhidrosis, Healthcare Innovation

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 5
Domain Associates, Morgenthaler Ventures +3
08 Jun 2016
Debt Financing $4.33M -
23 May 2016
Debt Financing $1.26M -
24 Dec 2015
Series D $26.01M 5
Domain Associates, Morgenthaler Ventures +3
06 Oct 2014
Debt Financing $5.00M -
11 Dec 2013
Series C $36.00M -
31 May 2011
Debt Financing $1.75M -
19 Nov 2010
Debt Financing $1.00M -
05 Oct 2010
Series B $20.30M 3
Morgenthaler Ventures, Split Rock Partners +1
15 Mar 2008
Series A $5.00M -
01 Feb 2006

Miramar Labs Alternatives & Competitors

Miramar Labs vs

Finally sweat has met its Patch!

Series B
28 employees
Health Care, Medical Devices
Miramar Labs vs
Revance
Revance United States

Developing neuromodulators for the treatment of aesthetic and therapeutic conditions

IPO
669 employees
Biotechnology, Health Care
Miramar Labs vs

Innovative solutions for minimally invasive emphysema treatment with a pioneering lung volume reduct...

Venture round
Biotechnology, Health Care

FAQ About Miramar Labs

Advanced medical devices specifically designed to address underarm hyperhidrosis in adults, providing targeted treatment for enhanced comfort and confidence.
Miramar Labs was founded in 2006.
Miramar Labs operates in Health Care, Medical Devices and Pharmaceutical. Its work centres on Hyperhidrosis Treatment, Aesthetic Treatment, Adult Healthcare and Medical Technology.
Miramar Labs has completed 10 funding rounds, raising a total of $100.65M. The latest funding stage is Venture round.
Top alternatives and competitors to Miramar Labs include Candesant Biomedical, Revance, PneumRx, Silk Road Medical, Inc., Zimmer MedizinSysteme GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Miramar Labs and Candesant Biomedical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Miramar Labs, https://bouncewatch.com/company/miramar-labs, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes